StarkAge Therapeutics
PrivateLast Round
VC Round
May 29, 2024
Total Funding Raised
$2.27M
Company Overview
StarkAge Therapeutics is a biotechnology company that develops first-in-class senolytic antibody–drug conjugates to address age-related diseases with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StarkAge Therapeutics Comparables
Compare StarkAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleara Biotech | 87% | |
| Deciduous Therapeutics | 86% | |
| Rubedo Life Sciences | 85% | |
StarkAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 29, 2024 | ||||
| Grant | Jan 19, 2022 |
StarkAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2024
$1.3M raised with Bpifrance participation.
- Jan 19, 2022
$2.27M grant received from Bpifrance.
StarkAge Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StarkAge Therapeutics's valuation, stock price, and market status.